These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 13891895)

  • 1. [Changes in the activity of basic phosphatases under the influence of massive doses of pyramidon].
    FAZEKAS IG; FAZEKAS AG; RENGEI B
    Kiserl Orvostud; 1961 Dec; 13():569-73. PubMed ID: 13891895
    [No Abstract]   [Full Text] [Related]  

  • 2. Changes in serum aldolase and alkaline phosphatase activity as effect of large doses of pyramidon (aminopyrine).
    FAZEKAS IG; FAZEKAS AG; RENGEI B
    Enzymologia; 1962 Jan; 24():7-13. PubMed ID: 13891894
    [No Abstract]   [Full Text] [Related]  

  • 3. [Changes in protein fractions of the blood serum under the influence of large doses of pyramidon].
    FAZEKAS IG; RENGEI B; FAZEKAS AG
    Kiserl Orvostud; 1962 Apr; 14():161-4. PubMed ID: 13891897
    [No Abstract]   [Full Text] [Related]  

  • 4. [Pharmacodynamic reactive changes related to the developmental stage. Studies on the drop in temperature in young and mature rats under the influence of increasing doses of pyramidon. II].
    KURZEPA S; RUTKOWSKA A
    Acta Physiol Pol; 1962; 13():301-6. PubMed ID: 14460856
    [No Abstract]   [Full Text] [Related]  

  • 5. Experimental examination of the mechanism of pyramidon effect. Effect of high pyramidon doses on renal function.
    FAZEKAS IG; FAZEKAS AG; BERTOK EF
    Arch Int Pharmacodyn Ther; 1960 Dec; 129():35-61. PubMed ID: 13698453
    [No Abstract]   [Full Text] [Related]  

  • 6. [Changes of glutamic-oxalic acid transaminase activity of the blood serum (SGOT) after massive doses of pyramidon].
    FAZEKAS A; FAZEKAS G; GYULA IG; RENGEI B
    Kiserl Orvostud; 1960 Oct; 12():490-3. PubMed ID: 13698446
    [No Abstract]   [Full Text] [Related]  

  • 7. Changes in glutamic acid-oxaloacetic acid-transaminase activity in the liver and kidneys on the effect of high doses of Pyramidon (aminopvrine).
    FAZEKAS IG; FAZEKAS AG; RENGEI B
    Can J Biochem Physiol; 1961 Jul; 39():1189-91. PubMed ID: 13698454
    [No Abstract]   [Full Text] [Related]  

  • 8. [The change of blood protein fractions following administration of large doses of pyramidon].
    FAZEKAS IG; RENGEI B; FAZEKAS AG
    Arch Toxikol; 1962; 19():321-4. PubMed ID: 13891898
    [No Abstract]   [Full Text] [Related]  

  • 9. [On induction of thermoregulatory reactions in the dog under the influence of aminopyrine].
    GOETTE D
    Pflugers Arch Gesamte Physiol Menschen Tiere; 1961; 274():192-212. PubMed ID: 13899504
    [No Abstract]   [Full Text] [Related]  

  • 10. The influence of age on phosphatase activity in the liver of the mouse.
    ZORZOLI A
    J Gerontol; 1955 Apr; 10(2):156-64. PubMed ID: 14367783
    [No Abstract]   [Full Text] [Related]  

  • 11. Experimental examination of the mechanism of pyramidon effect. 3. Effect of high pyramidon doses on the glutamic acid-oxaloacetic acid transaminase activity in serum.
    FAZEKAS AG; FAZEKAS IG; RENGEI B
    Can J Biochem Physiol; 1960 Aug; 38():899-901. PubMed ID: 13698448
    [No Abstract]   [Full Text] [Related]  

  • 12. [On the problem of the mechanism of convulsions induced by pyramidon].
    BRIN BM; KHUBETSOVA RD; STRESHNEVA NV
    Biull Eksp Biol Med; 1959 Sep; 48():98-100. PubMed ID: 13804445
    [No Abstract]   [Full Text] [Related]  

  • 13. [On the analgesic strength of pyramidon, butazolidin and carisoprodol in comparison with that of aspirin].
    FROMMEL E; FLEURY C; SCHMIDT-GINZKEY J
    Helv Physiol Pharmacol Acta; 1960; 18():109-11. PubMed ID: 13825366
    [No Abstract]   [Full Text] [Related]  

  • 14. [Pharmacodynamic reactivity changes in relation to the stage of development. I. Studies on the effect of pyramidon on brain tissue respiration in young and adult rats].
    KURZEPA S; RUTKOWSKA A
    Acta Physiol Pol; 1962; 13():167-75. PubMed ID: 14460857
    [No Abstract]   [Full Text] [Related]  

  • 15. [Testing of antirheumatic agents such as prednisolone, phenylbutazone, pyramidon and aspirin on depolarization thrombosis in cats].
    ALEXANDER K; KELLER H
    Arch Int Pharmacodyn Ther; 1962 Jan; 135():118-26. PubMed ID: 13860340
    [No Abstract]   [Full Text] [Related]  

  • 16. [Effect of large doses of pyramidon on glutamic-oxalic transaminase activity in the liver and kidneys].
    FAZEKAS IG; FAZEKAS AG; RENGEI B
    Kiserl Orvostud; 1961 Mar; 13():82-5. PubMed ID: 13698455
    [No Abstract]   [Full Text] [Related]  

  • 17. [Variation of the alkaline phosphatase activity in the alpha-cells of the islets of the pancreas under the influence of insulin and various other factors].
    VERNE J; PETTKOFF P
    Ann Endocrinol (Paris); 1961; 22():500-5. PubMed ID: 13780953
    [No Abstract]   [Full Text] [Related]  

  • 18. [Action of vitamin D2 in massive doses on the growth and phosphatase activity of a transplantable fibrosarcoma in the rat].
    BENDANDI A; DELLA CASA O; BENATTI G
    Arch Int Pharmacodyn Ther; 1954 Sep; 99(1):91-6. PubMed ID: 13229422
    [No Abstract]   [Full Text] [Related]  

  • 19. [Histo-chemical research on the changes in the activity of various enzymes under the influence of low concentrations of alcohol in cellular tissue cultures].
    TEOHAROV B; VELITCHKOV V; STEPHANOWA Z
    Ann Histochim; 1961; 6():523-5. PubMed ID: 13920260
    [No Abstract]   [Full Text] [Related]  

  • 20. [Antirheumatic therapy and hemostasis; research on the influence of pyramidon on the process of blood coagulation].
    CROLLE G; BIANCO S
    Minerva Med; 1956 May; 47(38):1457-60. PubMed ID: 13334113
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.